Trial Profile

An European, observational, multicenter, post-approval, open-enrollment study evaluating the real-world effectiveness and safety of Alofisel (darvadstrocel) in patients with Crohn's disease (CD) and complex perianal fistulas

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

17 Oct 2023 According to a Takeda media release, approximately 800 patients have been enrolled in this study.
23 Feb 2022 New trial record
18 Feb 2022 According to a Takeda media release, Professor Oded Zmora, Colon and Rectal Surgeon and Chair of the Department of Surgery, Shamir Medical Center, Tel Aviv, Israel, is the Chair of the INSPIRE steering committee.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com